Area development of Schapenweide, Bilthoven with 450 homes and life sciences businesses

Date:
Schapenweide, Bilt

The Municipality of De Bilt and the Dutch Central Government Real Estate Agency (Rijksvastgoedbedrijf) have signed a purchase agreement for the development of Schapenweide in Bilthoven. Following the development framework established last year, this marks a significant step forward for the area. In addition to 450 homes, the plan includes space for life sciences businesses.

Schapenweide

Schapenweide covers 13.3 hectares and is located near the village centre of Bilthoven, adjacent to the Houdringe and Beerschoten estates and the Panbos nature area, a popular destination for both recreation and sport. The area will feature a broad mix of rental and owner-occupied housing, catering to a wide range of residents. Alongside the 450 homes, the development framework allows for 25,000 square metres of life sciences business space.

Few available sites in De Bilt

Schapenweide is one of the few remaining development locations within the Municipality of De Bilt. The local housing market is extremely tight, making it difficult for people to find suitable accommodation. The Central Government Real Estate Agency and the Municipality of De Bilt have worked constructively together to create a development framework for Schapenweide, after which AM was selected as the purchaser through a joint selection process.

“We are extremely pleased with this step and our collaboration with AM,” said Anne Marie ’t Hart, Alderman for the Municipality of De Bilt. “The sale of Schapenweide enables us to develop a future-proof and sustainable residential area that meets the growing demand for housing. We are confident that, together with AM, we can create a neighbourhood for the future.”

Inventum site and more

AM previously developed the former Inventum site in Bilthoven and is active in several other projects across the region, including the Merwedekanaalzone and Leidsche Rijn in Utrecht, as well as Hoef en Haag in the municipality of Vijfheerenlanden.

In the coming period, the development vision for Schapenweide will be translated into concrete plans, in close dialogue with stakeholders. Interested parties are welcome to register, including those who wish to contribute ideas.

UtrechtInc has been recognized in the Financial Times “Europe’s Leading Startup Hubs 2026” ranking.

UtrechtInc has been recognized in the Financial Times “Europe’s Leading Startup Hubs 2026” ranking.

While UtrechtInc is proud of this recognition, the real stars of the story are the entrepreneurs, researchers, and students who walk through its doors every day.

Hardloopsymposium

Are you participating in the Utrecht Marathon or are you a keen runner? Register for the Running Symposium on March 19th.

On Sunday, May 31st, Utrecht Science Park will once again be the setting for the Utrecht Marathon. Thousands of runners will line up at the starting line to achieve a fantastic feat: running a quarter, half, or full marathon! To help you prepare optimally, the Utrecht Science Park Foundation, in collaboration with partners Utrecht University, UMC Utrecht, Utrecht University of Applied Sciences, and Olympos Sports Centre, is organizing a running symposium where you’ll be informed and inspired to get the most out of your running performance.

utrechtinc validation program

Applications Now Open for UtrechtInc Validation Programmes

Have you ever wondered what it takes to turn research or an idea into a startup? The validation programmes offered by UtrechtInc may provide the first step. Applications are now open.

Utrecht Science Park researchers receive prestigious Cancer Grand Challenge grants

Several research groups, including researchers from UMC Utrecht, the Princess Máxima Center, and the Hubrecht Institute, have been selected for a prestigious Cancer Grand Challenge (CGC) grant. Cancer Grand Challenges was co-founded in 2020 by Cancer Research UK and the National Cancer Institute in the United States. The initiative supports international, multidisciplinary research teams focusing on major challenges in cancer research.